MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

13 Aug 2026 Evaluate
The topline stands at Rs. 141.78 millions for the June 2026 quarter. The mentioned figure indicates a rise of about 90.26% as against Rs. 74.52 millions during the year-ago period.Net profit for the quarter ended June 2026 increased significantly by 53.68% to Rs. 10.65 millions from Rs. 6.93 millions.The company reported a good operating profit of 15.93 millions compared to 10.74 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 141.78 74.52 90.26 141.78 74.52 90.26 421.27 324.92 29.65
Other Income 6.83 5.54 23.29 6.83 5.54 23.29 21.29 10.24 107.91
PBIDT 15.93 10.74 48.32 15.93 10.74 48.32 54.66 27.33 100.00
Interest 0.41 0.18 127.78 0.41 0.18 127.78 1.63 1.27 28.35
PBDT 15.52 10.56 46.97 15.52 10.56 46.97 53.03 29.47 79.95
Depreciation 1.47 1.48 -0.68 1.47 1.48 -0.68 5.90 6.29 -6.20
PBT 14.05 9.08 54.74 14.05 9.08 54.74 47.13 23.18 103.32
TAX 3.40 2.15 58.14 3.40 2.15 58.14 11.31 5.77 96.01
Deferred Tax 0.14 0.16 -12.50 0.14 0.16 -12.50 0.82 1.23 -33.33
PAT 10.65 6.93 53.68 10.65 6.93 53.68 35.82 17.41 105.74
Equity 143.46 137.63 4.24 143.46 137.63 4.24 143.46 137.63 4.24
PBIDTM(%) 11.24 14.41 -22.04 11.24 14.41 -22.04 12.98 8.41 54.26
Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..